Keywords
Cigarette smoke, T-cells, circRNA, HIV
This article is included in the Cell & Molecular Biology gateway.
Circular RNAs (circRNAs), once thought to be a result of splicing errors, have been found to be involved in various molecular processes and the pathology of various diseases, including cancer and neurodegenerative diseases. Additionally, circRNA expression was found to be altered by lifestyle habits, such as smoking cigarettes. Past studies have revealed that the rate of smoking remains high in people living with human immunodeficiency virus (HIV). In this study, we isolated total RNA from uninfected T-cells that have been exposed to cigarette smoke and compared the expression levels of circRNAs to those of T-cells that were not exposed to cigarette smoke. We identified certain circRNAs that were upregulated or downregulated in T-cells when exposed to cigarette smoke. These data indicate that the study of circRNAs is warranted within the context of HIV.
Cigarette smoke, T-cells, circRNA, HIV
The Introduction section of our manuscript has been expanded to provide further explanation and clarification regarding the rationale behind the objectives of our experiment, as well as the potential contributions of the data to future research.
See the authors' detailed response to the review by Thivanka Muthumalage
See the authors' detailed response to the review by Meity Ardiana
See the authors' detailed response to the review by Zahraa Rahal
Circular RNAs (circRNAs) are endogenous non-coding RNAs covalently bonded circular structures that are created through back-splicing events (Yu & Kuo, 2019). CircRNAs are predominantly present in the cytoplasm, but have also been shown to be present in extracellular vesicles (EVs) released from cells (Gotts et al., 2018; Preußer et al., 2018). Although first thought to be a result of splicing errors, circRNAs have been found to play important roles in various molecular processes, such as functioning as microRNA (miRNA) sponges (Hansen et al., 2013). miRNAs are small non-coding RNAs that are involved in regulating protein production by binding to complementary sequences in the 3′ untranslated region of messenger RNAs (mRNAs) and preventing their translation into protein (Jonas & Izaurralde, 2015). By binding miRNAs, circRNAs can alleviate repression of linear mRNA targets and thus influence gene regulation.
In some cancers, including pancreatic and breast cancer, aberrant expression of circRNAs has been observed (Rong et al., 2021; Wang et al., 2019a, 2019b). Altered expression of circRNAs has also been associated with neurodegenerative diseases such as Alzheimer’s Disease (Lo et al., 2020). Together, these data suggest that circRNAs are involved in disease pathology and may serve as novel biomarkers for various diseases. Notably, lifestyle habits like cigarette smoking alter circRNA expression as well (Zeng et al., 2019), indicating that a person’s smoking status may impact epigenetic mechanisms mediated by miRNAs.
Although the rate of smoking in the general population has been on the decline, it remains higher in people living with human immunodeficiency virus (HIV) (Socio et al., 2020). The persistently high rate of smoking in people living with HIV has been found to be due to complex psychosocial characteristics and unhealthy behavioral factors including lower education and economic level, unemployment, depression, and drug usage (Yang et al., 2022). Individuals living with HIV who smoke tend to have a more serious prognosis or develop other HIV-related diseases such as cancers, pneumonia, and chronic obstructive pulmonary disease (COPD) (Giles et al., 2018; Hile et al., 2016), the pathophysiology of which may be impacted by epigenetic regulation of miRNAs and circRNAs. A significant amount of research over the years has found that HIV primarily infects T-cells and result in depletion of T-cells population through various mechanisms, including direct virus attack leading to cytolytic effect and chronic immune activation resulting in apoptosis (Vijayan et al., 2017). In the current study, we sought to investigate the effects of cigarette smoke on circRNA expression profiles in a model of uninfected human T-cells (H9 cells) to understand how cigarette smoke impacts circRNA expression in this cell type, a common target of HIV (Walker & McMichael, 2012). These data will provide a foundation for investigating circRNA expression in HIV-infected H9 cells that have been exposed to cigarette smoke to understand how these two variables intersect. Experiments conducted in China found a strong correlation between smoking and expression levels of unique circRNAs (hsa_circ_0049875 and hsa_circ_0042590) in COPD peripheral blood mononuclear cells (PBMCs), and the frequency of acute exacerbations was shown to be substantially linked with these circRNA expressions (Shen et al., 2024). These recent findings emphasize the importance of identifying circRNAs that could potentially serve as biomarkers of diseases affecting immune cells, like HIV, in the setting of cigarette smoke exposure. The data published in the manuscript could be utilized as a foundation for further exploration of circRNAs affected by cigarette smoke in HIV infected T-cells.
Cigarette smoke extract (CSE) was made using an apparatus and techniques as previously described by our lab (Bernstein et al., 2019). Briefly, 25 mL of R10 media, supplemented with 10% fetal bovine serum, 1 mM L-glutamine (Thermo Fisher, MA, USA; Cat #25030081), 1 mg/mL Pen-Strep (Thermo Fisher, MA, USA; Cat #15140148), and 10 mM HEPES (Thermo Fisher, MA, USA; CAT #15630080), was aliquoted into a 50 mL conical tube and sealed with parafilm. A 5 mL serological pipette, cut at the 3.5 mL mark, was inserted through the parafilm seal. This apparatus was connected to one end of a Tygon tubing (Cole-Parmer, Cat. No. 06509-17), which was inserted into a Cole-Parmer Masterflex L/S peristaltic pump at speed setting of 32. A 1 mL pipette tip was tightly inserted into the other end of the Tygon tubing. Next, one Spectrum research-grade cigarette (Richter et al., 2016) (filter intact) obtained through the National Institute of Drug Abuse was lit with a Bunsen burner and tightly inserted into the wide end of the 1 mL pipette tip. The cigarette was then smoked continuously by the peristaltic pump into the cell culture medium. The resulting product was considered 100% CSE. CSE media was created using the same paradigm each time, using Spectrum cigarettes that are tightly regulated by the FDA, and following the general techniques utilized by other similar studies (Comer et al., 2014; Hernandez et al., 2013; Ji et al., 2017; Kim et al., 2010).
H9 cells (passage 1-6) were used for all experiments, as these cells are commonly used for cancer and immunology research. Approximately 400,000 cells/mL of H9 cells were passaged into six T75 flasks and were exposed to either 0% or 50% CSEM. After 24 hours, the percentage of viable cells was measured ( Table 1) using a Muse cell counter and Muse Count & Viability Reagent (Luminex, Cat. No. MCH600103). H9 cells were used for this experiment specifically for their susceptibility to HIV-1 infections. Future experiments would be replicated with HIV-infected H9 cells so we can differentiate the effects of cigarette smoke extract on the control versus the HIV-infected cells.
Percentages of cell viability and density were measured and calculated after 24 hours for six flasks of H9 cells: three with 0% CSEM for 24 hours and three with 50% CSEM. CSEM, cigarette smoke extract media.
% CSEM | Viable cells/mL | % Viability |
---|---|---|
0% - flask #1 | 1,195,679 | 98.1 |
0% - flask #2 | 1,196,918 | 97.1 |
0% - flask #3 | 1,248,749 | 96.7 |
50% - flask #1 | 723,372.7 | 85.9 |
50% - flask #2 | 632,603.8 | 86.1 |
50% - flask #3 | 715,714.1 | 87.9 |
The Invitrogen mirVana™ miRNA Isolation Kit (ThermoFisher Scientific, Cat. No. AM1560) was used as directed to isolate total cellular RNA. Approximately 105 cells from each flask were lysed with 600 μL lysis buffer. Then, 750 μL 100% ethanol was added and centrifuged at 10,000 × g for 15 seconds. The filters containing RNA were washed, and total RNA was eluted with 100 μL pre-heated nuclease-free water, centrifuging at maximum speed for 25 seconds. RNA quality was checked using an Agilent Fragment Analyzer. Next, 5,000 ng of RNA from each sample was shipped to Arraystar for hybridization with the Human Circular RNA Array (Cat. No. AS-S-CR-H-V2.0).
Total RNAs from each sample were quantified using the NanoDrop ND-1000 and the integrity of the samples were evaluated through electrophoresis on a denaturing agarose gel. Total RNAs were then digested with RNase R (Epicentre, Inc.) to degrade linear RNAs and enrich circRNAs. A random priming method was used to amplify and transcribe the enriched circRNAs into fluorescent complementary RNAs (cRNAs) (Arraystar Super RNA Labeling Kit; Arraystar), which were then purified by RNeasy Mini Kit (Qiagen). Nanodrop ND-1000 was used to measure the concentration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA). A total of 1 μg of each labeled cRNA was fragmented by adding 5 μl of 10× Blocking Agent and 1 μl of 25× Fragmentation Buffer. The mixture was then incubated at 60°C for 30 minutes, then 2× Hybridization buffer was added to dilute the labeled cRNA. Then, 50 μl of the hybridization solution was dispensed into the gasket slide and assembled to the circRNA expression microarray slides, which were washed, fixed, and scanned with the Agilent Scanner G2505C.
Agilent Feature Extraction Software (version 11.0.1.1) (RRID:SCR_014963) was used to extract raw data from the scanned images. Quantile normalization of the raw data and subsequent data processing were conducted using the R software Limma package (RRID:SCR_010943). Low intensity filtering was then performed to retain circRNAs that at least one out of six samples were flagged as “present” or “marginal”. The quality control flags of “present”, “marginal”, or “absent” were determined based on various features, including positive and significant signal, saturation, population outlier, above background, and uniformity of the background. The fold change between the cigarette exposed samples and control samples were calculated and the statistical significance of the difference was estimated using an unpaired t-test. circRNAs having fold changes greater than or equal to 1.5 and p-values less than or equal to 0.05 were selected as significantly differentially expressed, using Microsoft Excel (RRID:SCR_016137). The false detection rate for each differentially expressed circRNAs were calculated using Benjamini-Hochberg procedure. These data, while suggestive, do not support robust statistical analysis secondary to the number of repeats and the large number of RNAs.
The Human Circular RNA Array revealed 234 circRNAs that were 1.5-fold upregulated (Up Regulated circRNAs) and 42 circRNAs that were 1.5-fold downregulated (Down Regulated circRNAs) in H9 cells cultured in 50% CSEM relative to H9 cells grown in 0% CSEM (Hong et al., 2023).
Gene Expression Omnibus: Cigarette Smoke Alters CircRNA Expression in Human T-Cells. GSE228979; https://identifiers.org/geo/GSE228979 (Hong et al., 2023).
This series contains the following underlying data:
- Datasheet 1 (1.5 Fold Up Regulated circRNAs. Datasheet 1 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 234 circRNAs that were significantly upregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or other literatures).
- Datasheet 2 (1.5 Fold Down Regulated CircRNAs. Datasheet 2 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 42 circRNAs that were significantly downregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or PMIDs).
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for creating the dataset(s) clearly described?
Yes
Are the protocols appropriate and is the work technically sound?
Partly
Are sufficient details of methods and materials provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: I am quite knowledgeable in stem cell
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: I study smoking-induced (cigarette and waterpipe) lung cancer.
Is the rationale for creating the dataset(s) clearly described?
Partly
Are the protocols appropriate and is the work technically sound?
Partly
Are sufficient details of methods and materials provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: I study smoking-induced (cigarette and waterpipe) lung cancer.
Is the rationale for creating the dataset(s) clearly described?
Partly
Are the protocols appropriate and is the work technically sound?
Partly
Are sufficient details of methods and materials provided to allow replication by others?
No
Are the datasets clearly presented in a useable and accessible format?
Partly
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Inhalation toxicology and lung biology
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 3 (revision) 09 Apr 25 |
|||
Version 2 (revision) 14 Jun 24 |
read | read | |
Version 1 30 May 23 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)